Online Matchmaking: MultiPMData2026

1 Oct 2025 – 27 Apr 2026

Register
Register
Register

4D Fusion sp. z o.o.

Enterprise – Startups, SMEs, and industry companies

4dfusion.euBieruń, Poland
1 profile visit

About

4D Fusion sp. z o.o. is a European deep-tech company offering a unique multi-material additive manufacturing platform that accelerates the development of advanced polymers, composites and functional structures for medical, pharmaceutical and personalised-medicine applications. Our patent-pending BFG extrusion technology, combined with modular clear extrusion capabilities enables fast formulation, testing and 3D printing of new biomaterials — including biosoluble and biodegradable polymers for controlled release of active pharmaceutical ingredients (API) — using only gram-scale inputs, fully controlled compositions without the need for process additives, and precise adjustment of functional additive levels up to 75% vol..

Our 4D Fusion AM System supports clean, low-temperature extrusion profiles compatible with APIs sensitive to thermal degradation, and allows printing customised drug-delivery geometries (micro-reservoirs, lattices, multilayer structures) that can be personalised to the patient. With multi-material, on-the-fly printing, the system can also create zonal release profiles, gradient structures, and embedded functional layers, enabling new concepts in smart therapeutics.

Beyond solid dosage forms, our technology supports the fabrication of biosoluble wearables and patches capable of releasing APIs through skin contact. These elements can be personalised in form, stiffness and dissolution rate, while the printing process maintains high material purity thanks to our modular, easily sterilizable material-insert system. Safety considerations — accidental ingestion, child safety, recyclability — can be directly addressed through tailored material formulations and controlled dissolution kinetics.

The platform is designed for both research and scalable production, bridging medical material development and regulatory-ready manufacturing. It allows rapid iteration cycles, minimal waste, and precise tuning of functional additives (from <1% to >75% vol.), supporting applications such as drug-delivery devices, biosensors, antimicrobial materials, personalised implants and advanced polymer systems for health technologies.

4D Fusion is building a European ecosystem linking medical research institutions, pharma innovators and material-science labs to accelerate the development of next-generation personalised-medicine materials and devices. Our mission is to provide partners with fast, flexible and safe routes from concept to functional medical prototypes and early-stage production.

We are seeking partners to further develop and apply our technology in personalised medicine, enabling the creation of hospital‑printed 3D dosage forms with precisely controlled drug‑release profiles, tailored at the level of pharmaceutical composition and patient‑specific therapeutic needs.

Representatives

Founder / CEO

4D Fusion sp. z o.o.